Mylan (MYL) Receives FDA Approval for Generic Version of Takeda's Actoplus Met

June 27, 2012 1:30 PM EDT Send to a Friend
Bloomberg reporting Mylan (NYSE: MYL) has won FDA approval for its generic version of Takeda's actoplus met.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Rumors

Add Your Comment